As of 30 September 2021

£1.2bn

Net assets

172p

NAV per share

(11.4)%

NAV per share growth over previous 6 months

£618m

Value of life science portfolio

(21.3)%

Return from life science portfolio over previous 6 months

£535m

Capital pool